Localized proton magnetic resonance spectroscopy (MRS) of the human brain, first reported
more than 20 years ago, 1–3 is a mature methodology that is used clinically in many medical …

Magnetic resonance imaging (MRI) provides anatomic images and morphometric
characterization of disease, whereas magnetic resonance spectroscopy (MRS) provides …

Magnetic resonance spectroscopy (MRS) is a technique that combines the ability of nuclear
magnetic resonance (NMR) to differentiate molecules with the imaging features of …

Intraaxial brain masses are a significant health problem and present several imaging
challenges. The role of imaging is no longer limited to merely providing anatomic details …

Accurate diagnosis is essential for optimum management and treatment of patients with
brain tumours. Proton magnetic resonance spectroscopy (1H MRS) provides information …

MRI has a vital role in the assessment of intracranial lesions. Conventional MRI has limited
specificity and multiparametric MRI using diffusion-weighted imaging, perfusion-weighted …

Establishing the diagnosis of a brain tumour is not always a straightforward process. Many
non-neoplastic neurological diseases can mimic brain neoplasms on neuroimaging or on …

Purpose: To develop and retrospectively determine the accuracy of a magnetic resonance
(MR) imaging strategy to differentiate intraaxial brain masses, with histologic findings or …

Proton magnetic resonance spectroscopy (1H MRS) non-invasively provides information on
the biochemical profile (typically including up to nine metabolites and mobile lipids) of brain …

Background: Demyelinating lesions over 20 mm in size, referred to as tumefactive
demyelinating lesions, can be misdiagnosed as being either a tumor or an abscess …